A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process ...
Repare Therapeutics Inc. (NASDAQ:RPTX – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 1,130,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback